Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.22.1
Segment Information
 3 Months Ended
Apr. 02, 2022
Segment Reporting [Abstract]  
Segment Information

Note 20: Segment Information

The Company operates within targeted markets through three reportable segments for continuing operations: biotechnology, recycling, and technology. The biotechnology segment commenced operations in September 2019 and is focused on development of new and innovative solutions for ending the opioid epidemic ranging from digital technologies to educational advocacy. The recycling segment includes all fees charged and costs incurred for collecting, recycling and installing appliances for utilities and other customers. The recycling segment also includes byproduct revenue, which is primarily generated through the recycling of appliances. The technology segment designed wireless modules to connect devices to the Mobile Internet of Things (“IoT”) which contain location-based service (“LBS”) capabilities and can interface to external sensors to allow them to communicate both sensor status and position information. The nature of products, services and customers for each segment varies significantly. As such, the segments are managed separately. Our Chief Executive Officer has been identified as the Chief Operating Decision Maker (“CODM”). The CODM evaluates performance and allocates resources based on sales and income from operations of each segment. Operating loss represents revenues less cost of revenues and operating expenses, including certain allocated selling, general and administrative costs. There are no intersegment sales or transfers.

The following tables present our segment information for the 13 weeks ended April 2, 2022 and April 3, 2021 (in $000's):

 

 

Thirteen Weeks Ended

 

 

April 2, 2022

 

 

April 3, 2021

 

Revenues

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

9,324

 

 

 

8,672

 

Technology

 

—

 

 

 

—

 

Total Revenues

$

9,324

 

 

$

8,672

 

Gross profit

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

1,853

 

 

 

1,421

 

Technology

 

—

 

 

 

—

 

Total Gross profit

$

1,853

 

 

$

1,421

 

Operating loss

 

 

 

 

 

Biotechnology

$

(242

)

 

$

(242

)

Recycling

 

(846

)

 

 

(928

)

Technology

 

(4

)

 

 

(939

)

Total Operating loss

$

(1,092

)

 

$

(2,109

)

Depreciation and amortization

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

131

 

 

 

108

 

Technology

 

2

 

 

 

937

 

Total Depreciation and amortization

$

133

 

 

$

1,045

 

Interest (income) expense, net

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

192

 

 

 

73

 

Technology

 

—

 

 

 

—

 

Total Interest expense, net

$

192

 

 

$

73

 

Net income (loss) before benefit from income taxes

 

 

 

 

 

Biotechnology

$

(242

)

 

$

(242

)

Recycling

 

1,490

 

 

 

1,639

 

Technology

 

(34

)

 

 

(897

)

Total Net income (loss) before benefit from income taxes

$

1,214

 

 

$

500

 

 

 

 

 

As of
April 2,
2022

 

 

As of
January 1,
2022

 

Assets

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

16,535

 

 

 

15,165

 

Technology

 

 

—

 

 

 

—

 

Total Assets

 

$

16,535

 

 

$

15,165

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

214

 

 

 

268

 

Technology

 

 

—

 

 

 

—

 

Total Intangible assets

 

$

214

 

 

$

268